Kloxxado Patent Expiration

Can you believe KLOXXADO received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10973814 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US10722510 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US11135155 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US11617713 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)

US11628139 HIKMA Liquid naloxone spray
Aug, 2034

(10 years from now)



Kloxxado is a drug owned by Hikma Pharmaceuticals Usa Inc. It is used for reversing the effects of opioid overdose in both adult and pediatric patients. Kloxxado uses Naloxone Hydrochloride as an active ingredient. Kloxxado was launched by Hikma in 2021. It is is available in spray form for nasal use. Its generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be Aug 26, 2034 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Apr 29, 2024

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using NALOXONE HYDROCHLORIDE ingredient

Market Authorisation Date: 29 April, 2021

Treatment: Use of naloxone for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients

Dosage: SPRAY

How can I launch a generic of KLOXXADO before it's drug patent expiration?
More Information on Dosage

KLOXXADO family patents

Family Patents